H+H International A/S (HH)
Copenhagen Exchange · Denmark · prices in DKK · close of 22 Oct 2026
Key indicators
| Last close | DKK 94.30 |
|---|---|
| 52-week range | 75.10 – 116.00 |
| Return, 1 month / 3 months | −1.6% / −5.7% |
| Return, 1 year / 3 years | −9.3% / +25.6% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 40.7% |
| Worst drawdown (1 year) | -25.5% |
| Average daily value traded | 1.86M DKK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
H+H International A/S makes aerated concrete building products, chiefly blocks and panels used for walls in residential and commercial construction. The company supplies builders, contractors and distributors, and its materials are used for both new build and renovation work. It is based in Denmark and serves markets across Europe, with production and sales operations in several countries. Its products are known for combining insulation and structural performance in a single building material.
The shares are listed on the Copenhagen Exchange in Denmark under the code HH, and the price on this page is in Danish kroner (DKK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
H+H International A/S (HH) trades on the Copenhagen Exchange in Denmark. It last closed at DKK 94.30 on 22 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 114 of 164 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.3% and over the last three months it fell 5.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Copenhagen Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -1.6% | ||
| From 52-week high | -15.7% | ||
| Momentum | 27 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.7% | ||
| 6-month return | -15.7% | ||
| 12-month return, skipping the last month | -7.9% | ||
| Stability (higher is calmer) | 38 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.5% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.86M DKK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −0.1% |
|---|---|
| 1 month | −1.6% |
| 3 months | −5.7% |
| 6 months | −15.7% |
| 1 year | −9.3% |
| 3 years | +25.6% |
| 5 years | −63.4% |
Signals
| 50-day / 200-day average | 98.82 / 95.88 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.43 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Copenhagen Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.